低分子肝素治疗急性冠状动脉综合征的疗效及护理

Efficacy and Care of the Low Molecular Weight Heparin in the Treatment of Acute Coronary Syndrome

目的观察低分子肝素钙和普通肝素治疗急性冠状动脉综合征(ACS)的疗效及安全性,总结护理经验。方法将47例患者随机分为两组,低分子肝素组(26例),普通肝素组(21例),观察两组治疗前、后的疗效。结果两组患者治疗后心绞痛均较治疗前缓解,两组总有效率比较无显著性差异(88.5%:81.0%,P>0.05),低分子肝素组的出血并发症少于普通肝素组,但无统计学意义(P>0.05)。结论低分子肝素和普通肝素治疗急性冠状动脉综合征均有效,但低分肝素出血并发症少,无须监测,使用安全方便。

Objective To observe the clinical effects and security of LMWHC（LowMolecular Haparin Calcium） and UTH（UnfractionatedHeparin） on treatment of acute coronary syndrome（ACS）,and summarize the nursing experience.Methods Totally 47 patients were randomized into two groups： LMWHC group with 26 cases and UTH group with 21 cases.Relief of the symptoms and bleeding were observed.Results Angina pectoris was relieved in both groups after the treatment,and there was no significant difference in total effcacy rate（88.5% versus 81.0%,P〈0.05）.The LMWHC group had less bleeding complications than UTH group,but no statistics differences was observed（P〈0.05）.Conclusion LMWH and UTH were both effective for the treatment of ACS,but LMWHC has less bleeding complications.